141. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial. (21st September 2018) Authors: Mullens, Wilfried; Verbrugge, Frederik H.; Nijst, Petra; Martens, Pieter; Tartaglia, Katrien; Theunissen, Evi; Bruckers, Liesbeth; Droogne, Walter; Troisfontaines, Pierre; Damman, Kevin; Lassus, Johan; Mebazaa, Alexandre; Filippatos, Gerasimos; Ruschitzka, Frank; Dupont, Matthias Journal: European journal of heart failure Issue: Volume 20:Number 11(2018) Page Start: 1591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
142. Rationale and design of the AFFIRM‐AHF trial: a randomised, double‐blind, placebo‐controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron‐deficient patients admitted for acute heart failure. (28th December 2019) Authors: Ponikowski, Piotr; Kirwan, Bridget‐Anne; Anker, Stefan D.; Dorobantu, Maria; Drozdz, Jarosław; Fabien, Vincent; Filippatos, Gerasimos; Haboubi, Teba; Keren, Andre; Khintibidze, Irakli; Kragten, Hans; Martinez, Felipe A.; McDonagh, Theresa; Metra, Marco; Milicic, Davor; Nicolau, José C.; Ohlsson, ... Journal: European journal of heart failure Issue: Volume 21:Number 12(2019) Page Start: 1651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
143. Rationale and design of the CONFIRM‐HF study: a double‐blind, randomized, placebo‐controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency. (August 2014) Authors: Ponikowski, Piotr; van Veldhuisen, Dirk J.; Comin‐Colet, Josep; Ertl, Georg; Komajda, Michel; Mareev, Viacheslav; McDonagh, Theresa A.; Parkhomenko, Alexander; Tavazzi, Luigi; Levesque, Victoria; Mori, Claudio; Roubert, Bernard; Filippatos, Gerasimos; Ruschitzka, Frank; Anker, Stefan D. Journal: ESC heart failure Issue: Volume 1:Number 1(2014:Sep.) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
144. Rationale for and design of the TRUE‐AHF trial: the effects of ularitide on the short‐term clinical course and long‐term mortality of patients with acute heart failure. (13th November 2016) Authors: Packer, Milton; Holcomb, Richard; Abraham, William T.; Anker, Stefan; Dickstein, Kenneth; Filippatos, Gerasimos; Krum, Henry; Maggioni, Aldo P.; McMurray, John J.V.; Mebazaa, Alexandre; O'Connor, Christopher; Peacock, Frank; Ponikowski, Piotr; Ruschitzka, Frank; van Veldhuisen, Dirk J.; Holzmeist... Journal: European journal of heart failure Issue: Volume 19:Number 5(2017) Page Start: 673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
145. Recommendations on pre‐hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. (21st May 2015) Authors: Mebazaa, Alexandre; Yilmaz, M. Birhan; Levy, Phillip; Ponikowski, Piotr; Peacock, W. Frank; Laribi, Said; Ristic, Arsen D.; Lambrinou, Ekaterini; Masip, Josep; Riley, Jillian P.; McDonagh, Theresa; Mueller, Christian; deFilippi, Christopher; Harjola, Veli‐Pekka; Thiele, Holger; Piepoli, Massimo F... Journal: European journal of heart failure Issue: Volume 17:Number 6(2015) Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
146. Reply to Letter to the Editor "Endothelial dysfunction in Takotsubo syndrome". (1st May 2017) Authors: Naegele, Matthias; Flammer, Andreas J.; Enseleit, Frank; Ruschitzka, Frank; Noll, Georg; Sudano, Isabella Journal: International journal of cardiology Issue: Volume 234(2017) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
147. Reply: Impact of Cardio-Renal Syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up. (1st May 2018) Authors: Nowak, Albina; Siegenthaler, Martin; Namdar, Mehdi; Ruschitzka, Frank Journal: International journal of cardiology Issue: Volume 258(2018) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
148. Retinal microvascular dysfunction in heart failure. (21st October 2017) Authors: Nägele, Matthias P; Barthelmes, Jens; Ludovici, Valeria; Cantatore, Silviya; von Eckardstein, Arnold; Enseleit, Frank; Lüscher, Thomas F; Ruschitzka, Frank; Sudano, Isabella; Flammer, Andreas J Journal: European heart journal Issue: Volume 39:Number 1(2018) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
149. Retinal microvascular dysfunction in patients with coronary artery disease with and without heart failure: a continuum?. (4th July 2019) Authors: Barthelmes, Jens; Nägele, Matthias P.; Cantatore, Silviya; Novruzov, Etibar; Ludovici, Valeria; von Eckardstein, Arnold; Frank, Michelle; Ruschitzka, Frank; Sudano, Isabella; Flammer, Andreas J. Journal: European journal of heart failure Issue: Volume 21:Number 8(2019) Page Start: 988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
150. Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Issue 10240 (13th June 2020) Authors: Mehra, Mandeep R; Ruschitzka, Frank; Patel, Amit N Journal: Lancet Issue: Volume 395:Issue 10240(2020) Page Start: 1820 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗